Gastroesophageal Reflux Does Not Alter Effects of Body Mass Index on Risk of Esophageal Adenocarcinoma
- 1 January 2014
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 12 (1) , 45-51
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Central Adiposity Is Associated With Increased Risk of Esophageal Inflammation, Metaplasia, and Adenocarcinoma: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2013
- Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON ConsortiumInternational Journal of Epidemiology, 2012
- Influence of obesity on the risk of esophageal disordersNature Reviews Gastroenterology & Hepatology, 2011
- Obesity and Cancer: The Role of Dysfunctional Adipose TissueCancer Epidemiology, Biomarkers & Prevention, 2009
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- Body-Mass Index and Symptoms of Gastroesophageal Reflux in WomenNew England Journal of Medicine, 2006
- Obesity and Estrogen as Risk Factors for Gastroesophageal Reflux SymptomsJAMA, 2003
- Association between Body Mass and Adenocarcinoma of the Esophagus and Gastric CardiaAnnals of Internal Medicine, 1999
- Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal AdenocarcinomaNew England Journal of Medicine, 1999
- Body Mass Index and Risk of Adenocarcinomas of the Esophagus and Gastric CardiaJNCI: Journal of the National Cancer Institute, 1998